Biopharma dealmaking activity remained strong in October, with total deal value reaching $31.86 billion, a 17% increase from $27.15 billion in September and ranking as the second-highest month in 2025 ...

The contours of a reshaped and expanded electorate are coming into focus, with network exit poll results providing an early look at which groups shifted the most from the 2016 to 2020 presidential ...